What’s New At Embassy House?

Black and white portrait of a smiling Asian woman with her hair pulled back, wearing a black shirt, against a plain background.
A skateboard with yellow and green wheels mounted on the wall, a black and yellow backpack hanging next to it, and a framed picture of a young skateboarder performing a trick
Group of five people taking a selfie at an indoor event, smiling and having a good time.
Modern office building with signs for Forskarén, Spago Anomedical, Active Biotech, Ecophon, Carbtiq, Aventure, and Phi, featuring glass architecture and an outdoor seating area with benches and a small tree.
Anocca Raises SEK 440 Million to Advance TCR-T Cell Therapy Development
Funding, Members Embassy House Funding, Members Embassy House

Anocca Raises SEK 440 Million to Advance TCR-T Cell Therapy Development

Anocca AB, a clinical-stage biopharmaceutical company based in Sweden, has successfully raised approximately SEK 440 million (USD 46 million) in a new financing round. This funding will accelerate the development of VIDAR-1, Anocca’s gene-edited TCR-T cell therapy targeting mutant KRAS in pancreatic cancer, and support its preclinical programs.

Read More